Effect of redox modulating NRF2 activators on chronic kidney disease - Wikidata - awgldk - TriplyDB

Effect of redox modulating NRF2 activators on chronic kidney disease

Effect of redox modulating NRF2 activators on chronic kidney disease

http://www.wikidata.org/entity/Q26827726

about

Silymarin as a Natural Antioxidant: An Overview of the Current Evidence and Perspectives What is Known Regarding the Participation of Factor Nrf-2 in Liver Regeneration?Discovery of direct inhibitors of Keap1-Nrf2 protein-protein interaction as potential therapeutic and preventive agents Anti-Inflammatory Therapy Modulates Nrf2-Keap1 in Kidney from Rats with Diabetes Stabilization of endogenous Nrf2 by minocycline protects against Nlrp3-inflammasome induced diabetic nephropathy Oxidative Stress and Response to Thymidylate Synthase-Targeted Antimetabolites Non-alcoholic fatty liver disease: an emerging driving force in chronic kidney disease.Special issue: redox active natural products and their interaction with cellular signalling pathways.Grape seed powder improves renal failure of chronic kidney disease patients.15-Deoxy-Δ12,14-prostaglandin J2 Exerts Antioxidant Effects While Exacerbating Inflammation in Mice Subjected to Ureteral Obstruction.Role of Nuclear Factor Erythroid 2-Related Factor 2 in Diabetic Nephropathy.Association between non-matured arterio-venus fistula and blood pressure in hemodialysis patients.Cancer Cell Growth Is Differentially Affected by Constitutive Activation of NRF2 by KEAP1 Deletion and Pharmacological Activation of NRF2 by the Synthetic Triterpenoid, RTA 405.Restoration of Nrf2 Signaling Normalizes the Regenerative Niche.Integrated transcriptomic and proteomic analyses uncover regulatory roles of Nrf2 in the kidney.Uremic Toxicity of Advanced Glycation End Products in CKD.Farnesoid X Receptor Protects against Kidney Injury in Uninephrectomized Obese Mice.Sulforaphane Attenuates Contrast-Induced Nephropathy in Rats via Nrf2/HO-1 Pathway.Curcumin and chronic kidney disease (CKD): major mode of action through stimulating endogenous intestinal alkaline phosphatase.Curcumin, inflammation, and chronic diseases: how are they linked?Nrf2 Weaves an Elaborate Network of Neuroprotection Against Stroke.Nrf2: a potential therapeutic target for diabetic neuropathy.Identification of a functional antioxidant responsive element in the promoter of the Chinese hamster carbonyl reductase 3 (Chcr3) gene.Abnormal expression of Nrf2 may play an important role in the pathogenesis and development of adenomyosis.Genetic and Pharmacologic Targeting of Glycogen Synthase Kinase 3β Reinforces the Nrf2 Antioxidant Defense against Podocytopathy.Protective effects of sulforaphane on di-n-butylphthalate-induced testicular oxidative stress injury in male mice offsprings via activating Nrf2/ARE pathway.Nrf2 deficiency promotes the progression from acute tubular damage to chronic renal fibrosis following unilateral ureteral obstruction.Resveratrol, an Nrf2 activator, ameliorates aging-related progressive renal injury.Oxidative Stress and Renal Fibrosis: Recent Insights for the Development of Novel Therapeutic Strategies.Mycophenolate mofetil and curcumin provide comparable therapeutic benefit in experimental chronic kidney disease: role of Nrf2-Keap1 and renal dopamine pathways.Brazil nut consumption modulates Nrf2 expression in hemodialysis patients: A pilot study.

P2860

Q26770933-AB721EEE-562D-4978-927C-87EB5EA3AF2E Q27006063-F135EA80-17C7-430E-8356-DED5C88B496E Q28085561-34995D72-A17D-4E6A-BD77-2068AA414B51 Q28387207-84A66788-248B-4662-A29E-0CD0332B5C05 Q28391260-13484F07-EBFE-4E98-A3D4-79140E81D356 Q28394674-B5E96FD3-D6A3-4DC1-8547-910B98C10BBD Q30235846-2A04B3D6-80C9-48EF-89DD-7B618F8D3C63 Q33359497-19E6E03B-AB04-4EDC-8ED6-058316935178 Q33436604-6B566E5C-445E-4CAE-96B5-457C45992EE1 Q33631228-F16EE97F-ED3B-408D-8440-E72B047D5D64 Q33645497-04B5D7FB-997B-475F-BCE9-DD4D6C6D59CD Q35065688-4FEE3410-5B76-4EE3-8B28-90996D076048 Q35753567-0F504D9C-D75E-4322-8447-CCC38D11ECBC Q35863707-1BAF34FE-8874-42DF-85CE-92F729F42C44 Q36364169-83169856-8F38-4BD1-9C58-C981A29154BE Q36514906-0FB9F49A-C115-4BFE-9193-2790C9C865AF Q36518342-87320480-0C66-4EDE-9F45-85C45C58CAD0 Q36666072-812751BF-6CA7-450F-B9E0-F684C0822D8F Q38283016-58B484AB-44F4-4189-BC37-21FAA7B75F3E Q38501499-57E05DBF-9A3C-4ABA-9EDD-4F4B7943CF5C Q38723314-0A932F6A-D49A-4DC7-8EC3-CE288B5CA2E6 Q39206295-CD1D246C-6D63-415F-B925-4BAC877D913B Q41442474-F32DA92B-D7C5-45A9-A3C7-62B82B9CA3F0 Q41444938-1B6A19C0-FFED-4BBF-8632-95AE17C95C7E Q42141815-3243596E-0694-490D-81DA-3196F2C998C8 Q46615389-8584193E-BA84-4966-B165-5183B08171DC Q47416018-BC9C5C6F-D144-4DB7-A536-B41D7485F520 Q50077100-F7F2ED66-6234-4C78-BCC6-83B82409F53D Q52674866-D72DE8FC-0210-4B52-B7A0-41DD471F9C6D Q53128566-6F727157-FDCA-4AC0-8247-81ACAF419756 Q53145548-5811A788-6060-414D-B27B-5DE2E0764605

P2860

Effect of redox modulating NRF2 activators on chronic kidney disease

http://www.wikidata.org/entity/Q26827726

description

2014 nî lūn-bûn

@nan

2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Effect of redox modulating NRF2 activators on chronic kidney disease

@ast

Effect of redox modulating NRF2 activators on chronic kidney disease

@en

Effect of redox modulating NRF2 activators on chronic kidney disease

@nl

type

label

Effect of redox modulating NRF2 activators on chronic kidney disease

@ast

Effect of redox modulating NRF2 activators on chronic kidney disease

@en

Effect of redox modulating NRF2 activators on chronic kidney disease

@nl

prefLabel

Effect of redox modulating NRF2 activators on chronic kidney disease

@ast

Effect of redox modulating NRF2 activators on chronic kidney disease

@en

Effect of redox modulating NRF2 activators on chronic kidney disease

@nl

P1433

Q26827726-DA51BEDE-B7A5-44AA-9BD4-96BD8948A54C

P1476

Q26827726-9C72C175-D025-4397-B279-4132C66D4E90

P2093

Q26827726-A8F40E9A-172F-49E4-9178-EA09928A2B5A

Q26827726-D0399D0F-5FB7-468B-8EC5-AD840B97A623

Q26827726-E4A45DF0-4333-4023-B691-20D163ECE1B4

P275

Q26827726-C126D69D-FAC7-433E-BFEC-5E2B24658C48

P2860

Q26827726-01CADA0F-AECF-43FA-A439-4591B983E5BE

Q26827726-01D48855-06B9-4BE1-B135-F48C6393C4B0

Q26827726-036D12E4-B232-43C7-BDF8-5742753E95B8

Q26827726-03B789B2-A03A-46E4-BE84-539DF0FC97DE

Q26827726-03F505F8-51C2-4CED-9133-E7FEA19532EB

Q26827726-0543F4F9-39C8-4439-9AE7-4B7E7F171E18

Q26827726-089E8B36-0AE2-4E4A-84F0-3AD0CF2AD35E

Q26827726-09053643-9ABB-45CC-9106-DCA3E40EE87A

Q26827726-0AF9ACD1-0A0F-4258-9CFC-BD30DC78BE72

Q26827726-0B2C3A33-6AE1-4FCE-BE48-DB546308C04A

P304

Q26827726-A8ADDD55-4542-4100-B75E-9C9504C54ED7

P31

Q26827726-1FF89816-467A-40E6-8065-0FDBD09F1466

Q26827726-270502A1-3257-40CF-B893-21D217CCC6FD

P3181

Q26827726-4D5346D0-7B1F-496B-B665-8E2763F7F76D

P356

Q26827726-E8690136-102D-4286-B8E3-64830B8ADF4E

P407

Q26827726-A16DF75A-9717-4454-BF3A-564305F80403

P433

Q26827726-7FFB0BC0-EF64-4AD8-BC15-F2EEC940AB12

P478

Q26827726-FF8CFD2C-C2FC-4DC6-BB12-2FC897ED8E8B

P577

Q26827726-C012CA3F-1E0A-4CC0-834A-FEA52BBFF58F

P5875

Q26827726-D5CB8C94-733E-4034-9E00-38949B43B852

P698

Q26827726-A7B13D17-D884-4AE6-B633-726FB7CF3BE6

P921

Q26827726-2788E211-B4D7-4B8D-86DF-6B3547258A2E

Q26827726-3D297033-A80F-47BC-850D-1268CF3352DB

Q26827726-733ED8CD-9D6E-4210-B4D3-DB81FC1158AE

Q26827726-F24BC8CB-87C4-40BA-805F-32CF037A54E5

P932

Q26827726-A305B059-E2FD-4E2E-B716-30C3D02821F8

P3181

P356

MOLECULES190812727

P1433

P1476

Effect of redox modulating NRF2 activators on chronic kidney disease

@en

P2093

Bo-hyun Choi

http://www.w3.org/2001/XMLSchema#string

Kyung-Shin Kang

http://www.w3.org/2001/XMLSchema#string

Mi-Kyoung Kwak

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution

P2860

Free radicals and antioxidants in normal physiological functions and human disease

Resveratrol scavenges reactive oxygen species and effects radical-induced cellular responses

Extremely potent triterpenoid inducers of the phase 2 response: correlations of protection against oxidant and inflammatory stress

Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain

New synthetic triterpenoids: potent agents for prevention and treatment of tissue injury caused by inflammatory and oxidative stress

Different Electrostatic Potentials Define ETGE and DLG Motifs as Hinge and Latch in Oxidative Stress Response

Structure of the BTB domain of Keap1 and its interaction with the triterpenoid antagonist CDDO

Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants

An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements

Nrf1 and Nrf2 regulate rat glutamate-cysteine ligase catalytic subunit transcription indirectly via NF-kappaB and AP-1

P304

12727-12759

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3070904

http://www.w3.org/2001/XMLSchema#string

P356

10.3390/MOLECULES190812727

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P577

2014-08-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264940583

http://www.w3.org/2001/XMLSchema#string

P698

25140450

http://www.w3.org/2001/XMLSchema#string

P921

DNA-binding protein

mechanism of action

transcription factor

chronic kidney disease

P932

6271622

http://www.w3.org/2001/XMLSchema#string